Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 36

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 36
---
holder approval for the Board to implement an additional reverse
stock split of the Company’s Common Stock, independent of the Authorized Reverse Stock Split. If the Reverse Stock Split is approved,
the Board will have the authority to effect two separate reverse stock splits of the Company’s Common Stock pursuant to the respective
stockholder approval. Each reverse stock split, if implemented, would be effected separately and at a ratio determined by the Board within
the applicable approved ranges. Assuming that the Board implements the maximum ratio of the Authorized Reverse Stock Split equal to 1-for-25
and assuming that the Board implements the maximum ratio of the Reverse Stock Split equal to 1-for-500, the aggregate effect would be
a reverse stock split at a cumulative ratio of 1-for-12,500. Each reverse stock split, if implemented, would be effected separately and
the Board will retain full discretion as to whether to implement, one, both, or neither of the approved reverse stock splits.

The text of the proposed
amendment to the Company’s Charter to effect the Reverse Stock Split is included as to this Proxy Statement (the
“Reverse Stock Split Charter Amendment”). If the Reverse Stock Split Proposal is approved by the Company’s stockholders,
the Company will have the authority to file the Reverse Stock Split Charter Amendment with the Secretary of State of the State of Delaware,
which will become effective upon its filing; provided, however, that the Reverse Stock Split Charter Amendment is subject to revision
to include such changes as may be required by the office of the Secretary of State of the State of Delaware and as the Board deems necessary
and advisable. The Board has determined that the amendment is advisable and in the best interests of the Company and its stockholders
and has submitted the amendment for consideration by our stockholders at the Special Meeting.

Reasons for the Reverse Stock Split

We are submitting this proposal
to our stockholders for approval in order to increase the trading price of our Common Stock to meet the minimum per share bid price requirement
for continued listing on The Nasdaq Capital Market. We believe increasing the trading price of our Common Stock may also assist in our
capital-raising efforts by making our Common Stock more attractive to a broader range of investors. Accordingly, we believe that the Reverse
Stock Split is in our stockholders’ best interests.

<div align='center'>22</div>

In addition, the Series Warrants include a provision that, conditioned
upon the receipt of Stockholder Approval as more fully described in Proposal No 1 – The